accessibility menu, dialog, popup

UserName
Viewing profile as user:

Furopyridines

Organic heterocyclic compounds that consist of a furan ring and a pyridine ring fused together to form a bicycle.
Molecular Weight (g/mol) 
  • (2)
  • (1)
  • (1)
  • (2)
  • (3)
  • (1)
  • (1)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
Quantity 
  • (11)
  • (1)
  • (2)
  • (4)
Percent Purity 
  • (1)
  • (1)
  • (4)
  • (6)
  • (4)
Boiling Point 
  • (1)
  • (1)
  • (1)
  • (2)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

special offers

  • (11)

brands

  • (1)
  • (1)
  • (11)
  • (49)
  • (2)
  • (1)
  • (41)
  • (21)
  • (7)
  • (11)

special interests

  • (24)

Molecular Weight (g/mol)

  • (2)
  • (1)
  • (1)
  • (2)
  • (3)
  • (1)
  • (1)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)

Quantity

  • (11)
  • (1)
  • (2)
  • (4)

Percent Purity

  • (1)
  • (1)
  • (4)
  • (6)
  • (4)

Boiling Point

  • (1)
  • (1)
  • (1)
  • (2)

Search Within Results
Keyword Search:
16 – 30 of 141 results
16

Cambridge Isotope Laboratories 2-Isopropyl-6-methyl-4-pyrimidinol (unlabeled) 100 ug/mL in acetonitrile 1 2 mL

2-Isopropyl-6-methyl-4-pyrimidinol (unlabeled) 100 ug/mL in acetonitrile 1 2 mL

ENCOMPASS
17

Medchemexpress LLC Navitoclax-piperazine | 2143096-93-7 | 99.7% | 973.63 | 1 ML
SDP

Navitoclax-piperazine (ABT-263-piperazine) is an analog of Navitoclax and acts as a BCL-XL inhibitor. It serves as the ligand for the target protein of PROTAC DT2216. This compound, when combined with an E3 ubiquitin ligase VHL ligand, can be used to synthesize PROTAC DT2216. PROTACs are compounds that leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • Analog of Navitoclax
  • Acts as a BCL-XL inhibitor
  • Serves as a ligand for target proteins
  • Can be used in the synthesis of PROTACs
  • Utilizes the ubiquitin-proteasome system for selective protein degradation

ENCOMPASS_PREFERRED
18

eMolecules​ 1140240-20-5 | FURO[2,3-C]PYRIDIN-7-AMINE | AstaTech | MFCD09834949 | 134.138 | C7H6N2O | 95.000 | Nc1nccc2ccoc12 | 1g | 417005755

FURO[2,3-C]PYRIDIN-7-AMINE | AstaTech | 1140240-20-5 | MFCD09834949 | 134.138 | C7H6N2O | 95.000 | Nc1nccc2ccoc12 | 1g | 417005755

ENCOMPASS_PREFERRED
19

eMolecules​ 5-CHLORO-2-METHYL-PYRIMI 100MG

5000190779 5-CHLORO-2-METHYL-PYRIMI 100MG

ENCOMPASS_PREFERRED
20

eMolecules​ 5-CHLORO-2-METHYL-PYRIMID 25MG

5000190781 5-CHLORO-2-METHYL-PYRIMID 25MG

ENCOMPASS_PREFERRED
21

eMolecules​ 3-PIPERAZIN-1-YLPROPIO 250MG

5000192536 3-PIPERAZIN-1-YLPROPIO 250MG

ENCOMPASS_PREFERRED
22

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000784151 3-PIPERAZIN-1-YLPR 250MG

ENCOMPASS_PREFERRED
23

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000758453 3-PIPERAZIN-1-YLPR 250MG

ENCOMPASS_PREFERRED
24

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000742693 3-PIPERAZIN-1-YLPR 5G

ENCOMPASS_PREFERRED
25

Ambeed AMBEED

5000888563 2-PIPERAZIN-1-YLPYRIMIDI 250MG

ENCOMPASS_PREFERRED
26

Ambeed AMBEED

5000868879 36-DIMETHYL-2-PYRIDINAMINE 1GR

ENCOMPASS_PREFERRED
27

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000758768 3-PIPERAZIN-1-YLPR 10G

ENCOMPASS_PREFERRED
28

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000759552 PIPERAZIN-1-YL4-4 250MG

ENCOMPASS_PREFERRED
29

eMolecules​ 27245-31-4 | 3-piperazin-1-ylpropanoic acid | Pharmablock | MFCD03161179 | 158.201 | C7H14N2O2 | 97.000 | OC(=O)CCN1CCNCC1 | 1g | 788480724

3-piperazin-1-ylpropanoic acid | Pharmablock | 27245-31-4 | MFCD03161179 | 158.201 | C7H14N2O2 | 97.000 | OC(=O)CCN1CCNCC1 | 1g | 788480724

ENCOMPASS_PREFERRED
30

eMolecules​ 5657-51-2 | Furo[3,4-b]pyridin-5(7H)-one | Ambeed | MFCD01860224 | 135.122 | C7H5NO2 | 95.000 | O=C1OCc2ncccc12 | 100mg | 525175499

Furo[3,4-b]pyridin-5(7H)-one | Ambeed | 5657-51-2 | MFCD01860224 | 135.122 | C7H5NO2 | 95.000 | O=C1OCc2ncccc12 | 100mg | 525175499

ENCOMPASS_PREFERRED